Fig. 5From: Transcranial pulsed ultrasound facilitates brain uptake of laronidase in enzyme replacement therapy for Mucopolysaccharidosis type I diseaseThe liver IDUA activity of MPS-I and B6 mice. Group 1: MPS-1 mice without any treatment (n = 3). Group 2: MPS-1 mice with laronidase 2.9 mg/kg injection (n = 4), measured 4 hours after injection. Group 3: normal B6 mice (n = 4). ** indicates p < 0.01Back to article page